SHELLY BROWN: Open Payments
NPI 1649555947 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 19 payments from 11 companies in 2025. Trend: 2023 $403 · 2024 $574 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $33 |
| Corium, LLC | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Qelbree, TRINTELLIX, REXULTI, VIVITROL, Azstarys, ABILIFY MAINTENA, ZURZUVAE, SPRAVATO.
Industry payments across OH — which companies pay providers there.
